London has among the highest HIV diagnosis rates in the UK. Spegra combines three antiretrovirals into one daily tablet, offering complete viral suppression with a high barrier to drug resistance, WHO-recommended as preferred first-line therapy. Spegra is a prescription antiretroviral medication used in the management of HIV-1 infection. It contains a combination of three active ingredients: Emtricitabine, Tenofovir Alafenamide, and Rilpivirine, which work together to help reduce the amount of HIV in the body and support long-term viral suppression when taken as prescribed.
Patients in London can access Spegra as an affordable generic alternative to Odefsey. When used consistently under medical supervision, it can help maintain a low viral load, improve immune system function, and support overall health outcomes for people living with HIV.
